Implantable glucose sensor for type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study is testing a new implantable sensor (the HALO System) that measures glucose levels continuously in people with type 1 diabetes. It aims to see if the sensor is safe and works well, which could eventually lead to a more convenient way to track glucose without frequent fingersticks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have been diagnosed with type 1 diabetes for at least 12 months.
- You must use an insulin pump (CSII) to manage your diabetes.
- You must be willing to visit the clinic often for blood draws and to take part in controlled challenges (like eating or exercise tests).
- You must be willing to charge the sensor every day and avoid placing your regular glucose monitor or insulin pump near the sensor site.
- You must not have certain health conditions, like heart disease, epilepsy, bleeding disorders, or anemia, and you cannot be pregnant or planning pregnancy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new glucose sensor placed inside a blood vessel to see how well it measures blood sugar. If you have diabetes and use intensive insulin therapy, this could be a way to help improve monitoring.
This study tests the ROME GS System, a glucose monitoring device that measures blood sugar levels. The system includes a sensor placed under the skin and a transmitter worn on the body. If you have diabetes and want to help evaluate a new way to track your blood sugar, this trial may be for you.
This study tests a new sensor system that tracks glucose levels continuously and can give a quick reading when you wave a device over it. It aims to see if it's safe and accurate for people with diabetes.
This trial studies how well a continuous glucose monitor (a sensor that tracks glucose) works for managing blood sugar in adults with type 1 or type 2 diabetes. You may need to wear sensors and have glucose levels adjusted during clinic visits to test safety and effectiveness.
This trial tests a new device that measures blood sugar and ketones continuously. It may help people with type 1 diabetes who use an insulin pump keep better track of their levels.
This study tests a device that measures both glucose and ketone levels continuously. It may help people with type 1 diabetes better manage their condition by providing real-time data.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.